AutoDNA: an AI-native autonomous laboratory for biomolecular engineering
AutoDNA is an AI-native biomolecular laboratory platform from Shanghai Jiao Tong University. The 2026-11-04 journal abstract reports orchestration of more than 20 instrument types over more than 11,000 steps, expert-level DNA-synthesis yields, 3.2-fold faster concurrent protocol execution, exact recovery of DNA-stored digital content and detection/validation of a known KRAS G13D mutation. Archived as platform and workflow validation: the reviewed material identifies no separate new biological finding or clinical study result qualifying as a catalog discovery.
Technology: AutoDNA AI-native autonomous laboratory (co-designed models, experiments and instruments)
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: Four platform demonstrations: enzymatic DNA synthesis, concurrent execution, DNA data storage and detection/validation of a known KRAS G13D mutation.
- Still unknown: Publisher main body is paywalled; scope was the abstract, affiliations, date, figure titles, captions and accessible back matter. No claim of full-paper review or absence of every possible application is made.
- AI role: AI models co-designed with experiments and instruments orchestrate the end-to-end workflow autonomously.
Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI%3A%2210.1038%2Fs41586-026-11228-6%22&resultType=core&format=json · https://www.nature.com/articles/s41586-026-11228-6
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review scope and date are not recorded; source checked does not establish full-text review.
Editorial assessment: Impact 4/5 · Validation 3/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.